Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Albumin vs Human Albumin in Cirrhosis with Ascites
CTR20212001Phase 2Completed
- Sponsor
- Beijing Anruite Biotechnology
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human albumin in Cirrhosis, ascites, hypoalbuminemia, sponsored by Beijing Anruite Biotechnology. Started Sep 2021; status: completed.
02
Drugs
recombinant human albumin
03
Conditions
Cirrhosisasciteshypoalbuminemia
Beyond the preview
Go deeper on CTR20212001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212001.